673 related articles for article (PubMed ID: 23382540)
1. Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.
Guazzi M; Labate V; Cahalin LP; Arena R
Eur J Prev Cardiol; 2014 Jul; 21(7):847-54. PubMed ID: 23382540
[TBL] [Abstract][Full Text] [Related]
2. Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.
Van Iterson EH; Johnson BD; Borlaug BA; Olson TP
Eur J Heart Fail; 2017 Dec; 19(12):1675-1685. PubMed ID: 28990307
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO
Klaassen SHC; Liu LCY; Hummel YM; Damman K; van der Meer P; Voors AA; Hoendermis ES; van Veldhuisen DJ
J Card Fail; 2017 Nov; 23(11):777-782. PubMed ID: 28736291
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342
[TBL] [Abstract][Full Text] [Related]
5. Predictors of abnormal heart rate recovery in patients with heart failure reduced and preserved ejection fraction.
Cahalin LP; Arena R; Labate V; Bandera F; Guazzi M
Eur J Prev Cardiol; 2014 Jul; 21(7):906-14. PubMed ID: 23335654
[TBL] [Abstract][Full Text] [Related]
6. Exercise ventilatory inefficiency in heart failure and chronic obstructive pulmonary disease.
Smith JR; Van Iterson EH; Johnson BD; Borlaug BA; Olson TP
Int J Cardiol; 2019 Jan; 274():232-236. PubMed ID: 30201380
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.
Shafiq A; Brawner CA; Aldred HA; Lewis B; Williams CT; Tita C; Schairer JR; Ehrman JK; Velez M; Selektor Y; Lanfear DE; Keteyian SJ
Am Heart J; 2016 Apr; 174():167-72. PubMed ID: 26995385
[TBL] [Abstract][Full Text] [Related]
8. A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction.
Popovic D; Arena R; Guazzi M
Eur J Heart Fail; 2018 Jul; 20(7):1115-1124. PubMed ID: 29405511
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol.
Shimiaie J; Sherez J; Aviram G; Megidish R; Viskin S; Halkin A; Ingbir M; Nesher N; Biner S; Keren G; Topilsky Y
JACC Heart Fail; 2015 Oct; 3(10):803-14. PubMed ID: 26449998
[TBL] [Abstract][Full Text] [Related]
12. The combined exercise stress echocardiography and cardiopulmonary exercise test for identification of masked heart failure with preserved ejection fraction in patients with hypertension.
Nedeljkovic I; Banovic M; Stepanovic J; Giga V; Djordjevic-Dikic A; Trifunovic D; Nedeljkovic M; Petrovic M; Dobric M; Dikic N; Zlatar M; Beleslin B
Eur J Prev Cardiol; 2016 Jan; 23(1):71-7. PubMed ID: 26358991
[TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
[TBL] [Abstract][Full Text] [Related]
14. Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data.
Athanasopoulos LV; Dritsas A; Doll HA; Cokkinos DV
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):375-9. PubMed ID: 19940776
[TBL] [Abstract][Full Text] [Related]
15. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
[TBL] [Abstract][Full Text] [Related]
16. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
17. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
18. IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
Van Tassell BW; Trankle CR; Canada JM; Carbone S; Buckley L; Kadariya D; Del Buono MG; Billingsley H; Wohlford G; Viscusi M; Oddi-Erdle C; Abouzaki NA; Dixon D; Biondi-Zoccai G; Arena R; Abbate A
Circ Heart Fail; 2018 Aug; 11(8):e005036. PubMed ID: 30354558
[TBL] [Abstract][Full Text] [Related]
19. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
20. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
Fudim M; Kelly JP; Jones AD; AbouEzzeddine OF; Ambrosy AP; Greene SJ; Reddy YNV; Anstrom KJ; Alhanti B; Lewis GD; Hernandez AF; Felker GM
Am Heart J; 2020 Feb; 220():97-107. PubMed ID: 31805424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
